Amanote Research
Register
Sign In
Sphingosine Induces Apoptosis and Down-Regulation of MYCN in PAX3–FOXO1-positive Alveolar Rhabdomyosarcoma Cells Irrespective of TP53 Mutation
Anticancer Research
- Greece
doi 10.21873/anticanres.12193
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Cancer Research
Oncology
Date
January 2, 2018
Authors
Unknown
Publisher
Anticancer Research USA Inc.
Related search
Alveolar Rhabdomyosarcoma – The Molecular Drivers of PAX3/7-FOXO1-induced Tumorigenesis
Skeletal Muscle
Orthopedics
Sports Medicine
Cell Biology
Molecular Biology
Alveolar Rhabdomyosarcoma–associated PAX3-FOXO1 Promotes Tumorigenesis via Hippo Pathway Suppression
Journal of Clinical Investigation
Medicine
Inhibiting Phosphorylation of the Oncogenic PAX3-FOXO1 Reduces Alveolar Rhabdomyosarcoma Phenotypes Identifying Novel Therapy Options
Oncogenesis
Cancer Research
Molecular Biology
Aurora a Kinase Inhibition Destabilizes PAX3-FOXO1 and MYCN and Synergizes With Navitoclax to Induce Rhabdomyosarcoma Cell Death
Cancer Research
Cancer Research
Oncology
Induction of Apoptosis in Rhabdomyosarcoma Cells Through Down-Regulation of PAX Proteins
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Carnitine Palmitoyltransferase 1A (CPT1A): A Transcriptional Target of PAX3-FKHR and Mediates PAX3-FKHR–dependent Motility in Alveolar Rhabdomyosarcoma Cells
BMC Cancer
Cancer Research
Oncology
Genetics
PAX3-FKHR Regulates the Expression of Pleiotrophin to Mediate Motility in Alveolar Rhabdomyosarcoma Cells
Journal of Cancer Research Updates
PAX3/7–FOXO1 Fusion Status in Older Rhabdomyosarcoma Patient Population by Fluorescent in Situ Hybridization
Journal of Cancer Research and Clinical Oncology
Medicine
Cancer Research
Oncology
P-Cadherin Is a Direct PAX3–FOXO1A Target Involved in Alveolar Rhabdomyosarcoma Aggressiveness
Oncogene
Cancer Research
Genetics
Molecular Biology
